Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 6033 | 99 | 0.3228 | 0.3515 | 0.0164 | 0.0163 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 6696 | 102 | 0.3587 | 0.3515 | 0.0152 | 0.0163 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 2 | 6975 | 120 | 0.3729 | 0.3515 | 0.0172 | 0.0163 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8744 | 163 | 0.4345 | 0.4180 | 0.0186 | 0.0173 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 6957 | 110 | 0.3281 | 0.3141 | 0.0158 | 0.0173 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 6615 | 115 | 0.3115 | 0.3141 | 0.0174 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 6437 | 120 | 0.3027 | 0.3141 | 0.0186 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 7790 | 111 | 0.3888 | 0.4180 | 0.0142 | 0.0173 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2686 | 53 | 0.1378 | 0.1687 | 0.0197 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 7134 | 125 | 0.4409 | 0.4477 | 0.0175 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7190 | 141 | 0.4434 | 0.4477 | 0.0196 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 7416 | 121 | 0.4589 | 0.4477 | 0.0163 | 0.0178 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 7861 | 159 | 0.4190 | 0.4213 | 0.0202 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8056 | 164 | 0.3782 | 0.4565 | 0.0204 | 0.0200 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7493 | 140 | 0.4000 | 0.4213 | 0.0187 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7654 | 162 | 0.3590 | 0.4565 | 0.0212 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 8355 | 177 | 0.4449 | 0.4213 | 0.0212 | 0.0200 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8079 | 212 | 0.4118 | 0.4364 | 0.0262 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 5769 | 132 | 0.2951 | 0.3050 | 0.0229 | 0.0212 |